Arteaga, Carlos L. External Author

Publications

Sort by

Selected publications

  • A phase ib study of alpelisib (BYL719), a PI3Kα-specific inhibitor, with letrozole in ER+/HER2- metastatic breast cancerClinical Cancer Research2017 Academic Article GET IT
    Times cited: 22